Injective drops 7.08% as sellers control trading near $5.25

Injective drops 7.08% as sellers control trading near $5.25
Injective drops 7.08% today to $5.25

Injective (INJ) is trading at $5.25, having fallen 7.08% over the past day. The asset currently sits below its key short- and medium-term moving averages, with long-term support still intact.

INJ price prediction
24H -13.14%
$4.43
48H -28.43%
$3.65
7D -24.51%
$3.85
1M 40.59%
$7.17
3M 245.49%
$17.62
6M 200.98%
$15.35
12M 171.96%
$13.87
Current price: $ 5.1 -0.68 11.70%
Real-time Data 10:36
Daily range 5.09 Arrow from to Icon 5.58
Weekly range 4.78 Arrow from to Icon 6.59
Loading...

Highlights

  • INJ/USD faces sustained bearish momentum, with price trading below key short- and medium-term moving averages.
  • Oversold conditions on multiple technical indicators point to stretched downside, yet ongoing selling pressure dominates intraday trades.
  • Near-term price is expected to fluctuate between $4.25 and $5.65, with a strong downside bias unless $5.55 resistance is reclaimed.

Bearish momentum intensifies as resistance holds on hourly chart

On the H1 timeframe, INJ/USD trades below the MA-20 at $5.51 and MA-50 at $5.59, but remains above the MA-200 at $4.21. The Ichimoku Kijun level at $5.55 acts as immediate resistance. Momentum indicators show a firmly negative outlook: MACD signals Sell, ADX is Neutral, and RSI reads 32.39. Both Stoch RSI and CCI are in oversold territory, while BBP points to seller dominance intraday. The Awesome Oscillator also supports this negative momentum profile.

Injective asset chart
Injective price dynamics. Source: TradingView.

Downside risk persists as consolidation expected within support band

Over the next 2–3 sessions, the expected volatility band for INJ/USD is $4.25 to $5.65. The likelihood of an upward breakout remains very low, with significant risk of further downside prevailing. Baseline expectation is for consolidation within this corridor, while a bullish scenario would require a sustained push above the $5.55 resistance. If the $4.25 support is lost, further declines could accelerate.

Viktoras Karapetjanc, expert at Traders Union, sees Injective trading under sustained bearish pressure despite holding above long-term support. The asset is oversold on multiple momentum indicators, with no clear news or macro sentiment triggers present. Consolidation between $4.25 and $5.65 is the main scenario unless $4.25 is lost. A bullish reversal would need a strong push above $5.55. "Given the current setup, I believe patient investors should watch for signs of reversal, but continued caution is warranted until momentum signals improve."

Earlier, analysts noted that Injective demonstrated bullish technical momentum and resilient network growth, supporting a positive outlook. However, the current shift to clearly negative momentum and a break below key moving averages marks a notable change, with traders now advised to monitor $4.25 as critical support amid heightened downside risk.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.